Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 μL | $199 | 7-10 days |
Description | Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P. |
Alias | VPF, VEGF-A, VEGF, MVCD1, L-VEGF |
Ig Type | Monoclonal Mouse IgG3 |
Clone | 9C236 |
Reactivity | Human |
Verified Activity | 1. Immunochemical staining of human VEGFA in human liver with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections). 2. Immunochemical staining of human VEGFA in human hepatoma with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections). |
Application | IHC-P |
Recommended Dose | IHC-P: 1:20-1:100 |
Antibody Type | Monoclonal |
Host Species | Mouse |
Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with a synthetic peptide corresponding to the C-terminus of the Human VEGF/VEGFA. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
Purification | Protein A |
Appearance | Liquid |
Formulation | 0.2 μm filtered solution in PBS |
Research Background | Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
Conjucates | Unconjugated |
Immunogen | A synthetic peptide corresponding to the C-terminus of the Human VEGF/VEGFA |
Antigen Species | Human |
Biology Area | Cancer Drug Targets |
Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.